From genomic analysis to deciphering development of pancreatic cancer liver metastasis
Pancreatic cancer adenocarcinoma (PDAC) is a dire disease with no good treatment and a five-year survival of only 5%. While most PDAC studies focus on cancer initiation and driver mutations, the majority of patients come to the clinic already with a metastatic disease, most frequently with liver metastasis, and most die directly from metastases.The research...